Medical Ikkou Group Co.,Ltd. (3353.T)
JPY 1972.0
(-0.35%)
JPY 1972.0
(-0.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.27 Billion | 1.3 Billion | 1.13 Billion | 1.82 Billion | 1.82 Billion | 516.46 Million |
| Net Income | 1.03 Billion | 1.31 Billion | 1.47 Billion | 1.44 Billion | 1.27 Billion | 1.16 Billion |
| Depreciation & Amortization | 783.87 Million | 841.58 Million | 870.47 Million | 837.71 Million | 825.9 Million | 849.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.26 Billion | -133.56 Million | -280.34 Million | 242.31 Million | -48.87 Million | -238.64 Million |
| Other non-cash items | -856.26 Million | -714.19 Million | -931.54 Million | -699.08 Million | -226.45 Million | -1.26 Billion |
| Investing Cash Flow | -3.21 Billion | -477.52 Million | -215.52 Million | -1.18 Billion | -375.02 Million | -1.34 Billion |
| Investments in PPE | -949.58 Million | -347.45 Million | -337.04 Million | -488.35 Million | -481.27 Million | -1.09 Billion |
| Acquisitions | -1.7 Billion | 69 Million | -11.9 Million | -665.33 Million | 41.89 Million | -713.4 Million |
| Investment purchases | -772.32 Million | -407.71 Million | -699.26 Million | -1.09 Billion | -285.21 Million | -173.82 Million |
| Sales/Maturities of investments | 578.49 Million | 306.88 Million | 750.1 Million | 1.11 Billion | 412.45 Million | 520.57 Million |
| Other Investing Activities | -374.22 Million | -98.23 Million | 82.6 Million | -43.56 Million | -62.89 Million | 115.94 Million |
| Financing Cash Flow | 277.75 Million | -2.36 Billion | 64.74 Million | 590.88 Million | -1.09 Billion | 474.85 Million |
| Debt repayment | -428.06 Million | -3.62 Billion | -3.62 Billion | -3.4 Billion | -3.94 Billion | -4.35 Billion |
| Dividends payments | -150.3 Million | -150.26 Million | -150.24 Million | -160.9 Million | -152.49 Million | -153.28 Million |
| Common Stock Repurchased | - | - | - | -271.92 Million | - | -80.68 Million |
| Common Stock Issuance | - | - | - | 4.42 Billion | - | 5.06 Billion |
| Other Financing Activities | -2000.00 | 1.41 Billion | 3.84 Billion | -3000.00 | 3 Billion | -1000.00 |
| Accounts receivables | 928.3 Million | -118.46 Million | -153.59 Million | 86.16 Million | -81.16 Million | -231.2 Million |
| Accounts payables | 1.74 Billion | -42.63 Million | -9.57 Million | 104.62 Million | 9.22 Million | -202.33 Million |
| Inventory | -60.15 Million | -14.21 Million | -119 Million | 49.54 Million | -95.69 Million | 130.54 Million |
| Other working capital | -352.62 Million | 41.76 Million | 1.82 Million | 1.98 Million | 118.76 Million | 64.35 Million |
| Cash at beginning of period | 6.25 Billion | 7.78 Billion | 6.8 Billion | 5.57 Billion | 5.21 Billion | 5.57 Billion |
| Cash at end of period | 7.58 Billion | 6.25 Billion | 7.78 Billion | 6.8 Billion | 5.57 Billion | 5.21 Billion |
| Capital Expenditure | -949.58 Million | -347.45 Million | -337.04 Million | -488.35 Million | -481.27 Million | -1.09 Billion |
| Effect of forex changes on cash | 110.86 Million | -1000.00 | -1000.00 | 1000.00 | -1000.00 | 1000.00 |
| Net cash flow / Change in cash | 1.33 Billion | -1.53 Billion | 984.26 Million | 1.23 Billion | 355.59 Million | -358.39 Million |
| Free Cash Flow | 3.32 Billion | 960.13 Million | 798 Million | 1.33 Billion | 1.34 Billion | -582.53 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 429 Million | 1.03 Billion | 227 Million | 368 Million | 233 Million | 211 Million |
| Depreciation & Amortization | - | 783.87 Million | - | 197.9 Million | 197.69 Million | 198.61 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 2.26 Billion | - | - | - | - |
| Other non-cash items | -429 Million | -856.26 Million | -227 Million | -368 Million | -233 Million | -211 Million |
| Investing Cash Flow | - | -3.21 Billion | - | - | - | - |
| Investments in PPE | - | -949.58 Million | - | - | - | - |
| Acquisitions | - | -1.7 Billion | - | - | - | - |
| Investment purchases | - | -772.32 Million | - | - | - | - |
| Sales/Maturities of investments | - | 578.49 Million | - | - | - | - |
| Other Investing Activities | - | -374.22 Million | - | - | - | - |
| Financing Cash Flow | - | 277.75 Million | - | - | - | - |
| Debt repayment | - | -428.06 Million | - | - | - | - |
| Dividends payments | - | -150.3 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -2000.00 | - | - | - | - |
| Accounts receivables | - | 928.3 Million | - | - | - | - |
| Accounts payables | - | 1.74 Billion | - | - | - | - |
| Inventory | - | -60.15 Million | - | - | - | - |
| Other working capital | - | -352.62 Million | - | - | - | - |
| Cash at beginning of period | - | 6.25 Billion | - | 6.54 Billion | 6.65 Billion | 6.25 Billion |
| Cash at end of period | - | 7.58 Billion | - | 7.81 Billion | 6.54 Billion | 6.65 Billion |
| Capital Expenditure | - | -949.58 Million | - | - | - | - |
| Effect of forex changes on cash | - | 110.86 Million | - | - | - | - |
| Net cash flow / Change in cash | - | 1.33 Billion | - | 1.26 Billion | -106.17 Million | 398.18 Million |
| Free Cash Flow | - | 3.32 Billion | - | 395.81 Million | 395.39 Million | 397.22 Million |
VIVHY
FCAFF
4506
LOVFF
DCHIF
002677